Investment will accelerate the overall Sarclisa® development program Sanofi will continue to fully manage the clinical program and retain full rights and control of Sarclisa® (isatuximab) PARIS — Sanofi and Blackstone (NYSE:… Read More
VANCOUVER, B.C. – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate… Read More
Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases NEW YORK — Pfizer Inc. (NYSE: PFE) announced today the… Read More
Dive Brief: Moderna will allow other vaccine makers to use its technology to make COVID-19 shots in 92 lower and middle-income countries, the company announced Monday. Elsewhere, however, the company “expects… Read More
OTTAWA, ONTARIO — When people began working from home and businesses went virtual at the start of the pandemic, telecommunications networks approached full capacity. The Canadian Photonics Fabrication Centre (CPFC)… Read More
